Becton Dickinson (NYSE: BDX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Heartflow disclosed the clearance alongside news that Cigna has become the second national insurer after UnitedHealthcare to ...
The innate immune system sees drugs as threats, but researchers are taking advantage of this response to make cancer therapies more effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback